Neurex Corporation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurex Corporation

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John O'Neill who wrote (417)	2/25/1998 9:09:00 PM
From: Dr. John M. de Castro	Read Replies (1) of 449

NTIIC was a temporary symbol used for NTI while they were under a temporary extension from delisting from the NASDAQ small cap market. Subsequently, I'm sorry to report, they were delisted and now trade on the OTC-BB under the symbol NTII. NTII has completed a Phase II trial for the treatment of peripheral neuropathies with Memantine. This is for pain management and they reported positive results for diabetic neuropathies. Memantine is an oral drug so it addresses a different market than NXCO's SNX-111 which requires intrathecal administration. IMO NTII's market is much larger than NXCO's. Take a look at the Neurobiological Technologies thread for more information in this regard. BTW: I am long in NTII and have a vested interest. John de C

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next